Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06328777 ×

NCT06328777

This funder is selected. Its supporting articles are shown below.

NCT063287771

Articles mentioning NCT06328777

1 articles · page 1 of 1

P.257 Reset-SSc: clinical trial evaluating rese-cel (resecabtagene autoleucel), a fully human, autologous 4-1BB CD19-CAR T cell therapy in systemic sclerosis

jsrd · abstract · 2026-06-05 · 1 matching annotations

79.3%

NCT06328777 systemic sclerosis (SSc)cyclophosphamide fludarabine SSc-Skin-1 rese-cel SSc-Skin-2 SSc-Skin-1Abstract

…the need for chronic immunomodulatory (IM) therapy. RESET-SSc ( NCT06328777) is an ongoing Phase 1/2 trial evaluating rese-cel in adult SSc…